WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Internet Technology Thursday, December 14, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email

Maxthon Backed New Cryptocurrency LivesToken (LVT) Launches Private Sale And Bounty Program
Friday, October 13, 2017

BEIJING, Oct. 13, 2017 /PRNewswire/ -- Maxthon, a global software company that develops advanced browsers, recently participated and endorsed a new blockchain project Symbiosism Chain. With the strong support coming from Maxthon, Symbiosism Chain officially launched private crowdsale for its new cryptocurrency called LivesToken (LVT). This shows that the world renowned browser developer is adapting itself to embrace the blockchain technology.

Users' daily Internet using behavior like account registration, content creating, browsing, commenting, sharing, and online shopping all generated value for businesses. But the users themselves did not receive any material reward. The emergence of the Symbiosism Chain is aiming to solve this problem by putting all Internet applications together to form an economic system. Users using applications that accessed to this system will be given material reward in the form of LivesToken (LVT) based on their online behaviors on a daily basis according to dynamic algorithm. On the other hand, users who possessed LVT can use it in the Symbiosism system to purchase value-added services. This could ultimately achieve the common benefits for both businesses and users.

The private crowdsale started a while ago and people can easily subscribe their preferred amount of LVT at with special discounts now. With Maxthon Browser's endorsement on technical support and resources, Symbiosism Chain is likely to be the first blockchain project that comes with a real and steady product but not just a concept. Plus, being the first business to participate in the Symbiosism system, Maxthon Browser itself can bring a lot of global users to the project to facilitate its maturity and prosperity. Thus, it's highly likely for the Symbiosism Chain issued cryptocurrency LivesToken (LVT) to increase steadily in value.

Besides, Symbiosism Chain also launched LivesToken Bounty Program to promote the token crowdsale by sending a certain amount of LivesToken to promoters as an incentive. Specific details of the program can be found at

About Maxthon & Symbiosism Chain

Founded in 2005, Maxthon is a global software company that develops state-of-the-art web browsers that give users a seamless browsing experience across multiple platforms. Maxthon browsers are used each month by more than 100 million people in 140 countries around the globe.

The Symbiosism Chain is a new blockchain project created by Jeff Chen, founder of Maxthon Browser, and its team. Its goal is to create a new business model based on the blockchain technology to achieve mutual improvement and common growth for both users and businesses. It can also solve the problem of user value realization by issuing a cryptocurrency LivesToken (LVT) to compensate the quantified value that users generated from their behaviors on the Internet.

More information about Symbiosism Chain and LivesToken's private crowdsale can be found at:

More information about Maxthon can be found at:

View original content:

SOURCE Maxthon

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Shawbrook Bank Strengthens Risk Management Capabilities with Hosted Spreadsheet Management Solution | Dec 14, 2017
Nav Severstal Project Boosts Engineering Design Efficiency with Intergraph Smart® 3D | Dec 14, 2017
Nav Herta: Safe City Project With Facial Recognition in Phuket | Dec 14, 2017
Nav TierPoint Achieves Microsoft Gold Cloud Platform Competency | Dec 14, 2017
Nav Chris McNabb, Dell Boomi CEO, Recognized by SIIA as Enterprise CEO of the Year | Dec 14, 2017
Nav Audio Precision Enables A2B® Audio Test | Dec 14, 2017
Nav Curisium Raises $3.5M to Scale Innovative Healthcare Contracting on Blockchain | Dec 14, 2017
Nav Technical Perspectives on TrovaGene, Accelerate Diagnostics, NeoGenomics, and Exact Sciences | Dec 14, 2017
Nav DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions | Dec 14, 2017
Nav Reveal Energy Services Delivers First Near Real-Time DiverterSCAN Technology Results | Dec 14, 2017

Submit News | View More News View More News